Evidence map›Paper›PMID 41692759›Full record

ArticleJournal of nanobiotechnology2026

A SERS-based biosensor for optical monitoring of PARP1 trapping dynamics and high-throughput screening of modulators.

Shizhi Xu, Ziming Wang, Baizhi Li, Jiayu Wang, Shai Fang, Wei Huang, Zhiyi Liu, Hongrui Li, Jinbao Xiang, Shuping Xu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shizhi Xu *Institute of Frontier Medical Sciences, Jilin University, Changchun, 130021, China.
Ziming Wang *Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar, 161006, China.
Baizhi LiInstitute of Frontier Medical Sciences, Jilin University, Changchun, 130021, China.
Jiayu WangInstitute of Frontier Medical Sciences, Jilin University, Changchun, 130021, China.
Shai FangState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, China.
Wei HuangInstitute of Frontier Medical Sciences, Jilin University, Changchun, 130021, China.
Zhiyi LiuInstitute of Frontier Medical Sciences, Jilin University, Changchun, 130021, China.
Hongrui LiInstitute of Frontier Medical Sciences, Jilin University, Changchun, 130021, China.
Jinbao XiangState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, China.
Shuping XuState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, China. xusp@jlu.edu.cn.
Chongyang LiangInstitute of Frontier Medical Sciences, Jilin University, Changchun, 130021, China. liang@jlu.edu.cn.

Funding

National Natural Science Foundation of China 22277039National Natural Science Foundation of China 22373041Science and Technology Development Program Projects of Jilin Province 20240305085YY
6 · The paper itself

Abstract

All clinically approved PARP1 inhibitors (PARPi) share NAD

Indexed as

Biosensing TechniquesHigh-Throughput Screening AssaysPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsSpectrum Analysis, RamanDNAHumansNADDNANADPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsHigh-throughput screeningPARP1 trappingPARP inhibitorsSERS biosensorSurface-enhanced Raman spectroscopy (SERS)

Identifiers

PMID41692759
PMCPMC13011414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.